Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

NZE/EBO stock hub

NZE/EBO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NZE/EBOis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.4B
New Zealand Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
NZE/EBO
In the news

Latest news · NZE/EBO

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.2
P25 8.8P50 14.2P75 20
Trailing P/E16.3
P25 10.4P50 17.5P75 22.4
ROE9
P25 -9.2P50 8.3P75 16.6
ROIC7.1
P25 -0.9P50 4.6P75 12.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NZE/EBO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
248
Groups with data
11
Currency
AUD
Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
New Zealand
Country code
NZ
Employees
5,800
Employees Change
30%
Employees Change Percent
0.52
Enterprise value
NZD 6.2B
Exchange
New Zealand Stock Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Medical Distribution
Isin
NZEBOE0001S6
Last refreshed
2026-05-10
Market cap
NZD 4.4B
Price
NZD 21.39
Price currency
NZD
Rev Per Employee
2,607,181.18x
Sector
Healthcare
Sic
5047
Symbol
nze/EBO
Website
https://www.ebosgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
6.01%
EV Earnings
23.33x
EV/EBIT
12.61x
EV/EBITDA
9.15x
EV/FCF
37.4x
EV/Sales
0.41x
FCF yield
3.75%
Forward P/E
14.17x
P/B ratio
1.41x
P/E ratio
16.33x
P/S ratio
0.29x
PE Ratio10 Y
28.06x
PE Ratio3 Y
26.66x
PE Ratio5 Y
25.23x
PEG ratio
5.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
3.15%
EBITDA Margin
3.82%
FCF margin
1.1%
Gross margin
13.08%
Gross Profit
NZD 2B
Gross Profit Growth
4.2%
Gross Profit Growth Q
8.61%
Gross Profit Growth3 Y
1.47%
Gross Profit Growth5 Y
1.97%
Net Income
NZD 266M
Net Income Growth
-6.67%
Net Income Growth Q
12.97%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
-5.46%
Net Income Growth5 Y
-1.96%
Pretax Margin
2.37%
Profit Margin
1.76%
Profit Per Employee
NZD 45,867
Profitable Years
22
ROA
3.56
Roa5y
4.31
ROCE
8.42
ROE
8.97
Roe5y
11.34
ROIC
7.14
Roic5y
9.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

29
MetricValue
Cagr10y
6.59%
Cagr15y
12.56%
Cagr1y
-40.2%
Cagr20y
13.04%
Cagr3y
-18.5%
Cagr5y
-3.81%
Div CAGR10
8.8%
Div CAGR3
5.13%
Div CAGR5
7.51%
EPS Growth
-11.14
EPS Growth Q
6.68
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
-7.18
EPS Growth5 Y
-3.2
FCF Growth
-58.54%
FCF Growth3 Y
-17.22%
FCF Growth5 Y
-13.6%
OCF Growth
-36.38%
OCF Growth Q
-75.47%
OCF Growth10 Y
0.82%
OCF Growth3 Y
-7.54%
OCF Growth5 Y
-6.8%
Revenue Growth
3.53x
Revenue Growth Q
12.96x
Revenue Growth Quarters
2x
Revenue Growth Years
0x
Revenue Growth3 Y
-0.37x
Revenue Growth5 Y
1.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
NZD 1.81
Assets
NZD 8.8B
Cash
NZD 302.8M
Current Assets
NZD 4.1B
Current Liabilities
NZD 3.3B
Debt
NZD 2.1B
Debt EBITDA
NZD 3.23
Debt Equity
NZD 0.68
Debt FCF
NZD 12.89
Equity
NZD 3.1B
Interest Coverage
3.45
Liabilities
NZD 5.7B
Long Term Assets
NZD 4.7B
Long Term Liabilities
NZD 2.4B
Net Cash
NZD -1.8B
Net Cash By Market Cap
NZD -41.49
Net Debt EBITDA
NZD 3.18
Net Debt Equity
NZD 0.59
Net Debt FCF
NZD 11.07
Tangible Book Value
NZD -166M
Tangible Book Value Per Share
NZD -0.81
WACC
5.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.24
Inventory Turnover
8.74
Net Working Capital
NZD 569.1M
Quick ratio
0.72
Working Capital
NZD 748.4M
Working Capital Turnover
NZD 25.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-5.07%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
NZD 1.32
Dividend Years
29
Dividend Yield
6.16%
Ex Div Date
2026-03-05
Last Dividend
NZD 0.6
Payout Frequency
Semi-Annual
Payout Ratio
57.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
89.29%
1Y total return
-40.18%
200-day SMA
28.29
3Y total return
-45.88%
50-day SMA
22.3
50-day SMA vs 200-day SMA
50under200
5Y total return
-17.66%
All Time High
46.75
All Time High Change
-54.25%
All Time High Date
2023-04-03
All Time Low
2.02
All Time Low Change
956.82%
All Time Low Date
1999-06-30
ATR
0.69
Beta
0.2
Beta1y
0.37
Beta2y
0.14
Ch YTD
-22.56
High
21.89
High52
41.98
High52 Date
2025-07-28
High52ch
-49.05%
Low
21.39
Low52
20.85
Low52 Date
2026-04-29
Low52ch
2.59%
Ma50ch
-4.1%
Price vs 200-day SMA
-24.38%
RSI
44.44
RSI Monthly
27.13
RSI Weekly
21.63
Sharpe ratio
-1.79x
Sortino ratio
-2.02
Total Return
1.09%
Tr YTD
-20.56
Tr15y
489.91%
Tr1m
-8.39%
Tr1w
0.47%
Tr3m
-14.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
NZD 475.9M
Operating Income Growth
-3.15
Operating Income Growth Q
-6.69
Operating Income Growth3 Y
-5.29
Operating Income Growth5 Y
-1.61
Operating margin
3.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
196,629,000%
Net Borrowing
10,315,693.5
Shares Insiders
0.17%
Shares Institutions
32.09%
Shares Out
206,929,602
Shares Qo Q
2.48%
Shares Yo Y
5.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

67
MetricValue
Adjusted FCF
NZD 169.3M
Average Volume
266,222.4x
Bv Per Share
15.56
CAPEX
NZD -153.1M
Ch10y
35.04
Ch15y
202.4
Ch1m
-8.39
Ch1w
0.47
Ch1y
-42.84
Ch20y
314.9
Ch3m
-16.48
Ch3y
-51.6
Ch5y
-30.12
Ch6m
-25.47
Change
-1.66%
Change From Open
-2.15
Close
21.75
Days Gap
0.51
Depreciation Amortization
105,942,136.2
Dollar Volume
7,873,252.6
Earnings Date
2026-05-25
EBIT
NZD 475.9M
EBITDA
NZD 577M
EPS
NZD 1.31
F Score
6
FCF
NZD 166M
FCF EV Yield
2.67x
FCF Per Share
NZD 0.8
Financing CF
149,765,047
Fiscal Year End
June
Founded
1,922
Goodwill
2,767,725,245.2
Graham Number
20.93084
Graham Upside
-2.15
Income Tax
NZD 91M
Investing CF
-450,688,681
Is Primary Listing
1
Last Earnings Date
2026-02-25
Last Report Date
2025-12-31
Last Split Date
2013-06-04
Last Split Type
Forward
Lynch Fair Value
NZD 6.43
Lynch Upside
-69.95
Ma150
25.82
Ma150ch
-17.17%
Ma20
21.73
Ma20ch
-1.56%
Net CF
14,344,658
Next Earnings Date
2026-05-25
Open
21.86
P FCF Ratio
26.67
P OCF Ratio
13.87
Payment Date
2026-03-27
Position In Range
0
Ppne
1,206,621,411.7
Price Date
2026-05-08
Price EBITDA
NZD 7.67
Relative Volume
1.41x
Revenue
15,121,650,856x
SBC By Revenue
-0.02x
Share Based Comp
-3,349,367
Tax By Revenue
0.6x
Tax Rate
25.4%
Tr20y
1,061.21%
Tr6m
-23.55%
Volume
368,081
Z Score
2.88
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NZE/EBO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+6.2%
$1.32 annual per share
Payout ratio
+57.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+7.5%
0 consecutive years of growth
Total shareholder yield
+1.1%
Next ex-dividend date: 2026-03-05
Performance

NZE/EBO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-40.2%
S&P 500 1Y: n/a
3Y total return
-45.9%
S&P 500 3Y: n/a
5Y total return
-17.7%
S&P 500 5Y: n/a
10Y total return
+89.3%
S&P 500 10Y: n/a
Ownership

Who owns NZE/EBO?

Insider, institutional, and short-interest positioning.

Institutional ownership
+32.1%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+5.1%
Negative means the company is buying back shares.
Technical

NZE/EBO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.4
Neutral momentum band
Price vs 200-day MA
-24.4%
50/200-day relationship not available
Beta (5Y)
0.20
Less volatile than the market
Sharpe ratio
-1.79
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NZE/EBO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nze/EBO stock rating?

nze/EBO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nze/EBO analysis?

The full report lives at /stocks/nze/EBO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nze/EBO?

The latest report frames nze/EBO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nze/EBO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.